Valeant’s Paulson Boost, Plus 2 Rival Drug Stocks Moving Big on Trial Data – Schaeffers Research (blog)

This Article Was Originally From This Site


Schaeffers Research (blog)

Valeant’s Paulson Boost, Plus 2 Rival Drug Stocks Moving Big on Trial Data
Schaeffers Research (blog)
The boost today sends CLVS stock to an 18-month high of $91, with the stock bouncing strongly off its 80-day moving average. Heading into today’s announcement, options traders were bracing for big moves from CLVS. The equity’s Schaeffer’s Volatility …

and more »

This Article Was Originally From *This Site*